¸ù¾Ý¹²Ê¶£¬ÔÚÉöÐÔÆ¶ÑªÖÎÁÆÁìÓò£¬³¤Ð§ÖƼÁÔÚÅ·ÃÀ¼°ÈÕ±¾µÈ¹ú¼ÒÒѹ㷺ʹÓ㬶øÎÒ¹úÈÔÒÔ¶ÌÐ§ÖØ×éÈËEPO£¨rHuEPO£©ÎªÖ÷¡£Ïà½ÏÓÚ¶ÌЧrHuEPO£¬³¤Ð§ÖƼÁ¿ÉÓÐЧ½µµÍ×¢É䯵´Î£¬¼õÉÙÒ½»¤ÈËÔ±¹¤×÷Á¿²¢ÌáÉý»¼ÕßÖÎÁÆÒÀ´ÓÐÔ£¬ÒѳÉΪ¸ÄÉÆÉöÐÔÆ¶ÑªÖÎÁƵÄÖØÒª·½Ïò¡£
±¾´Î¹²Ê¶ÍƼö³¤Ð§ºìϸ°ûÉú³É´Ì¼¤¼ÁÓÃÓÚÖÎÁÆ·Ç͸ÎöºÍ͸ÎöÒÀÀµÂýÐÔÉöÔಡ£¨CKD£©»¼Õߺϲ¢µÄÉöÐÔÆ¶Ñª£¨¾ùΪ1AÀàÖ¤¾Ý£©£¬Õ⽫½øÒ»²½Íƶ¯³¤Ð§ÖƼÁÔÚ¹úÄÚÁÙ´²Êµ¼ùÖеÄÓ¦Óã¬Ìá¸ßÎÒ¹úÉöÐÔÆ¶ÑªµÄ¹ÜÀíˮƽ¡£¹²Ê¶»¹½¨ÒéÔÚʹÓó¤Ð§ÖƼÁÖÎÁƹý³ÌÖÐӦעÒâ¼à²â°²È«ÐÔ£¬²¢Ö¸³öÅàĪɳëÄÓÉÓÚÔÚ°±»ùËáÐòÁÐÉÏÓëÄÚÔ´ÐÔEPOûÓÐͬԴÐÔ£¬Òò´Ë²»»áÓëÄÚÔ´ÐÔEPO·¢Éú½»²æÃâÒß·´Ó¦£¬´Ó¶øÄܹ»¸ü´ó³Ì¶ÈÉϱÜÃ⿹EPO¿¹Ìå½éµ¼µÄ´¿ºìϸ°ûÔÙÉúÕϰÐÔÆ¶Ñª£¨PRCA£©µÄ·¢Éú¡£ÅàĪɳëÄÊǵÏÍþÖÆµÏÍþ¹ú¼Ê×ÔÖ÷Ñз¢µÄ¡°È«ÇòΨһ»ñÅúÉÏÊеÄEPOÄ£ÄâëÄ¡±£¬2023Äê6Ô»ñNMPAÅú×¼ÉÏÊУ¬²¢ÒÑÄÉÈë2023Äê°æ¹ú¼ÒÒ½±£Ä¿Â¼£¬¿ªÆôÁËÎÒ¹úCKDÉöÐÔÆ¶Ñª³¤Ð§¹ÜÀíÐÂÆªÕ¡£ÓëÆäËû³¤Ð§ÖƼÁÏà±È£¬ÅàĪɳëĵĢóÆÚÁÙ´²Ñо¿Êý¾ÝÈ«²¿À´×ÔÖйúÈËȺ£¬¶Ô͸ÎöºÍ·Ç͸ÎöCKDƶѪ»¼Õß¾ùÓÐÈ·ÇÐÁÆÐ§£¬ÓÐÒæÓÚ¸üºÃµØÖ¸µ¼ÖйúÉöÐÔÆ¶Ñª»¼ÕßÓõÏÍþ¹ú¼Ê¡£2023Äê10Ô£¬È«Çò¶¥¼âҽѧÆÚ¿¯¡¶ÁøÒ¶µ¶¡·(The Lancet)×Ó¿¯eClinicalMedicine
(IF:15.1)ÔÚÏß·¢±íÁËÅàĪɳëÄ¢óÆÚÁÙ´²Ñо¿ÂÛÎÄ£¬ÕâÏîÕë¶Ô¶ÌЧrHuEPO
¾ÖεÄ͸ÎöƶѪ»¼ÕßµÄËæ»ú¡¢¿ª·ÅÐÔ¡¢ÑôÐÔ¶ÔÕÕ¡¢·ÇÁÓЧÐÔ¢óÆÚÊÔÑéÑо¿½á¹û֤ʵ£¬Ã¿ÔÂ1´ÎƤÏÂ×¢ÉäÅàĪɳëÄÓë³£¹æÃ¿ÖÜ1¡«3´Î¶ÌЧrHuEPO¸øµÏÍþ¹ú¼ÊͬÑùÓÐЧÇÒ°²È«¡£ËäÈ»ÊÇ·ÇÁÓЧÑо¿£¬µ«ÔÚÖ÷ÒªÁÆÐ§ÖÕµãÉÏÏÔʾ³öÓÅЧÐÔÇ÷ÊÆ£¨×é¼ä²îÒ죺0.29g/dL£¬95%
CI£º0.11¡«0.47£¬p=0.0018£©[2]¡£ÅàĪɳëÄ×÷ΪÎÒ¹ú×ÔÖ÷Ñз¢µÄ1ÀഴеÏÍþ¹ú¼Ê£¬ÔÚÉÏÊкó¿ìËÙ½øÈë¹ú¼ÒÒ½±££¬²¢±»ÄÉÈ롶ר¼Ò¹²Ê¶¡·£¬ÓÐЧÌá¸ßÁËÆäÁÙ´²¿É¼°ÐÔÓë¾¼ÃÐÔ£¬ÇÐʵÔ츣ÉöÐÔÆ¶Ñª»¼Õß¡£µÏÍþÖÆµÏÍþ¹ú¼Ê½«³ÖÐø×¨×¢ÓÅÊÆÁìÓò£¬¸ß¶È¾Û½¹Éî²ã´ÎÁÙ´²ÐèÇó£¬Ì½Ë÷²¢ÍƳö¸ü¶àÍ»ÆÆÐÔ´´ÐºõÏÍþ¹ú¼Ê£¬Ìá¸ßÈËÀàÉúÃüÖÊÁ¿¡£²Î¿¼ÎÄÏ×£º
[1] Öйú·Ç¹«Á¢Ò½ÔºÐ»áÉö²¡Í¸ÎöרҵίԱ»á¹²Ê¶×¨¼Ò×é. ³¤Ð§ºìϸ°ûÉú³É´Ì¼¤¼ÁÖÎÁÆÉöÐÔÆ¶ÑªÖйúר¼Ò¹²Ê¶£¨2024Äê°æ£©[J]. ÖлªÉöÔಡÔÓÖ¾,2024,40(2):146-157.
[2] Ping Zhang, et al. Pegmolesatide for the treatment of anemia in patients undergoing dialysis: a randomized clinical trial. eClinicalMedicine. 2023 Oct 28; 65:102273
×¢¡¤±¾ÎĽöÏÞÒ½ÁÆÐÐÒµÈËÊ¿ÔĶÁ²Î¿¼£¬²»×÷ΪÕïÁÆ»òÍÆ¼öÒÀ¾Ý¡£